2024
|
G/S
|
Pharmaceutical products, namely analgesics; anesthetic topical dermatological preparations; pharm... |
|
Invention
|
Methods and compositions for managing pain comprising dexmedetomidine transdermal compositions.
... |
|
Invention
|
Topical naloxone compositions and methods for using the same.
Aspects of the invention include t... |
2023
|
G/S
|
Transdermal patches for use in the management of pain; pharmaceutical topical preparations for us... |
|
G/S
|
Transdermal patches for use in the treatment of attention
deficit hyperactivity disorder, anxiet... |
2021
|
Invention
|
Topical naloxone compositions and methods for using the same. Aspects of the invention include to... |
2020
|
G/S
|
Pharmaceuticals for the treatment of cardiovascular conditions, allergies, central nervous system... |
2019
|
G/S
|
Transdermal patches for use in the treatment of attention deficit hyperactivity disorder, anxiety... |
|
Invention
|
Methods and compositions for treating attention deficit hyperactivity disorder, anxiety and insom... |
|
Invention
|
Flurbiprofen-axetil-containing fat emulsion and method for manufacturing same. [Problem] To provi... |
2018
|
Invention
|
Topical sphingosine-1-phosphate receptor agonist formulations and methods of using the same. Topi... |
|
Invention
|
Naloxone transdermal delivery devices and methods for using the same.
Naloxone transdermal deliv... |
|
Invention
|
Naloxone transdermal delivery devices and methods for using the same. Naloxone transdermal delive... |
|
G/S
|
Cosmetics; cosmetic preparations; adhesives for cosmetic purposes; cosmetic masks; non-medicated ... |
|
Invention
|
Rivastigmine transdermal compositions and methods of using the same. Rivastigmine transdermal com... |
2017
|
Invention
|
Methods of managing pain using dexmedetomidine transdermal delivery devices. Aspects of the inven... |
|
Invention
|
Methods of managing pain using dexmedetomidine transdermal delivery devices.
Aspects of the inve... |
2016
|
Invention
|
Non-aqueous taxane formulations and methods of using the same. Non-aqueous, ethanol-free taxane f... |
2015
|
Invention
|
Propynylaminoindan transdermal compositions. Propynylaminoindan (e.g., Rasagiline) transdermal co... |
|
Invention
|
Compositions and methods for transdermal delivery of hormones and other medicinal agents. The inv... |
2014
|
Invention
|
Methods and compositions for treating withdrawal syndromes using non-sedative dexmedetomidine tra... |
|
Invention
|
Dexmedetomidine transdermal delivery devices and methods for using the same. Aspects of the inven... |
|
Invention
|
Methods and compositions for managing pain comprising dexmedetomidine transdermal compositions. A... |
|
Invention
|
Methods and compositions for managing pain comprising dexmedetomidine transdermal compositions. T... |
|
Invention
|
Methods and compositions for transdermal delivery of a non-sedative amount of dexmedetomidine. As... |
|
Invention
|
Narcotic emulsion formulations for treatment of cancer pain. Methods and compositions of treating... |
|
Invention
|
Sphingosine-1-phosphate receptor agonist iontophoretic devices and methods of using the same. Ion... |
2013
|
Invention
|
Extended buprenorphine transdermal delivery compositions and methods for using the same. Aspects ... |
|
Invention
|
Non-aqueous taxane nanodispersion formulations and methods of using the same. Non-aqueous, ethano... |
2012
|
G/S
|
Cosmetics; cosmetic preparations; adhesives for cosmetic
purposes; cosmetic masks; soaps; perfum... |
|
G/S
|
[ Cosmetics; cosmetic preparations; adhesives for cosmetic purposes; cosmetic masks; soaps for pe... |
2011
|
G/S
|
Pharmaceutical research and development. |
|
G/S
|
Pharmaceutical research and development |
2010
|
G/S
|
Prescription and over-the-counter pharmaceutical preparations, namely, transdermal gel formulatio... |
2005
|
G/S
|
Analgesics in the form of a patch, all for use in the treatment of post-herpetic neuralgia. |